These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 19545554

  • 1. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
    Italia KY, Jijina FJ, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.
    Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
    [Abstract] [Full Text] [Related]

  • 2. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Sep; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 3. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
    Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.
    J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
    [Abstract] [Full Text] [Related]

  • 4. Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
    Ehsani MA, Hedayati-Asl AA, Bagheri A, Zeinali S, Rashidi A.
    Pediatr Hematol Oncol; 2009 Nov; 26(8):560-5. PubMed ID: 19954365
    [Abstract] [Full Text] [Related]

  • 5. Response to hydroxyurea therapy in beta-thalassemia.
    Koren A, Levin C, Dgany O, Kransnov T, Elhasid R, Zalman L, Palmor H, Tamary H.
    Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
    [Abstract] [Full Text] [Related]

  • 6. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
    Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.
    Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
    [Abstract] [Full Text] [Related]

  • 7. Hydroxyurea in thalassemia intermedia--a promising therapy.
    Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.
    Ann Hematol; 2005 Jul; 84(7):441-6. PubMed ID: 15838670
    [Abstract] [Full Text] [Related]

  • 8. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
    Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.
    Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
    Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P.
    Ann Hematol; 2004 Jul; 83(7):430-3. PubMed ID: 14722738
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.
    Garewal G, Das R, Ahluwalia J, Marwaha RK, Varma S.
    Am J Hematol; 2005 Aug; 79(4):252-6. PubMed ID: 16044458
    [Abstract] [Full Text] [Related]

  • 17. Asymptomatic and mild beta-thalassemia in homozygotes and compound heterozygotes for the IVS2+1G-->A mutation: role of the beta-globin gene haplotype.
    Ragusa A, Amata S, Lombardo T, Castiglia L, Maier-Redelsperger M, Labie D, Bernini L.
    Haematologica; 2003 Oct; 88(10):1099-105. PubMed ID: 14555304
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Do alpha deletions influence hydroxyurea response in thalassemia intermedia?
    Panigrahi I, Dixit A, Arora S, Kabra M, Mahapatra M, Choudhry VP, Saxena R.
    Hematology; 2005 Feb; 10(1):61-3. PubMed ID: 16019448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.